Melanomul malign

 Malignant melanoma

First published: 03 aprilie 2018

Editorial Group: MEDICHUB MEDIA

DOI: 10.26416/OnHe.42.1.2018.1556


I present a typical case of cutaneous melanoma located at the back of the chest. We describe the surgical protocol of the plastic surgery department of the Floreasca Emergency Hospital Bucharest for this type of cancer. The result of the biopsy (the histological examination) reveals a malignant melanoma indicating the depth at the skin level (Clark level) and lesion thickness (Breslow index). These elements are required for the indication of adjuvant treatment. The author also discusses the eventual classification of TNM for which he does not have all the necessary investigations

melanoma, surgery, stadialization


Se prezintă un caz tipic de melanom cutanat, localizat la nivelul toracelui posterior. Se descrie protocolul chirurgical al Secţiei de chirurgie plastică de la Spitalul de Urgenţă Floreasca Bucureşti pentru acest tip de cancer. Rezultatul biopsiei (examenul histologic) relevă un melanom malign la care se precizează profunzimea la nivelul straturilor pielii (nivelul Clark) şi grosimea leziunii (indicele Breslow). Aceste elemente sunt necesare pentru indicaţia de tratament adjuvant. Autorul  discută şi eventuala încadrare în clasificarea TNM, pentru care nu are toate investigaţiile necesare. 

Case report

A 69-year-old Romanian male patient was admitted to the Plastic Surgery Unit at the Floreasca Clinical Emergency Hospital Bucharest, complaining of the appearance of a cutaneous tumor on the back, interscapullary, which had been growing rapidly in size and had bled several times in the previous 6 months. It was a firm dark brown tumour, adherent to the skin, with no bleeding or ulceration at the moment of examination. The patient performed a dermatological consult which raised the suspicion of a malignant melanoma(1).

Figure 1. (left) Marking of the tumour and two Limberg flaps; Figure 2. (center) Depicts the defect resulted after the excision of the tumour; Figure 3. (right) The aspect of the excised tumour
Figure 1. (left) Marking of the tumour and two Limberg flaps; Figure 2. (center) Depicts the defect resulted after the excision of the tumour; Figure 3. (right) The aspect of the excised tumour

Considering the history of the lesion, the patient was admitted at the hospital, and after regular investigations (blood samples and EKG) he was planned for surgery. The surgery implied a circular incision with the electric cautery followed by another incision placed on the exterior of the previous one performed with a scalpel and the excision of the tumour with subcutaneous fat with 20 mm margin (Figures 1 and 2). The resulting defect was then covered by creating one local Limberg flap. After minutious haemostasis and adequate cleaning of the wound, the suture was performed in anatomical layers (Figure 4).

Figures 4, 5 and 6. Depict (from left to right) the postoperative aspect at 1, 8 and 21 days, respectively
Figures 4, 5 and 6. Depict (from left to right) the postoperative aspect at 1, 8 and 21 days, respectively

In the following days, the patient was assessed and dressings were performed daily. The evolution was favorable, with the wounds healing nicely, without any complications. On the third day, the patient was discharged from the hospital with the recommendations of continuing the antibiotherapy, the administration of pain killers (if needed), and follow-up at 7 and 14 days.

The histopathology result, which was ready 21 days after the operation, confirmed the initial suspicion and had the result of malignant melanoma with Clarck III and Breslow index >0.76 mm (approximately 1.3 mm) and complete excision of the tumor.


Malignant melanoma is not a rare disease in Romania. Being a serious illness, very aggressive and with potential of bad prognosis, it is of the outmost importance that is diagnosed as fast as possible, thus increasing the chances of survival(1).

Several studies have been performed on this subject, and in one of these Osterlind found that some characteristics influence the evolution of the disease, with women and younger patients having better prognosis and survival rates than men, and older people and better localized tumours being less aggressive than the disseminated ones(1,2).

The patient from our study had a localized lesion in the instercapullary region, but had higher risk, being an older-aged male.

Also, malignant melanoma seems to be more frequent in white people, as well as in Africans and others(3,4).

An important aspect is the classification of the malignant melanoma. Over the years, several classifications for malignant melanomas have been proposed, which include the Breslow, Clark and TNM classifications (the last being the most elaborate).

The more summarized versions are the first two, with Breslow indicating the depth of the lesion and offering a prediction of the future evolution, while Clark being used to describe mostly the thin forms of melanoma(5,6).

Breslow classification:

  • Thickness of 0.75 mm or less
  • Thickness of 0.76-1.5 mm
  • Thickness of 1.51-4 mm
  • Thickness greater than 4 mm.

Clark classification:

Level I – involves only the epidermis (in situ melanoma).

Level II – invades papillary dermis, but not the papillary-reticular interface.

Level III – invades the papillary dermis up to the interface, but without the reticular dermis.

Level IV – invades the reticular dermis, but not the subcutaneous tissue.

Level V – invasion into the subcutaneous tissue. 


Malignant melanoma is gaining a rapidly increasing incidence yearly worldwide. It remains an important and challenging issue because of the subclinical micrometastases that it may generate and which can affect the other organs in the same time in which the primary lesions is being treated. Hence the importance of clinical trials and screening in evading complications(1,6)

Conflict of interests: The author declares no conflict of interests.


  1. Yagi KI, Wani HU, Tinguria MB, Al-Qahtani DM. Malignant melanoma of the skin: a case report from the eastern region (Dammam Central Hospital), Saudi Arabia and epidemiological review. Journal of Family & Community Medicine. 2000; 7(2):67-71.
  2. Osterlind A, Kjems E. Survival of Danish Cancer Patients 1943-1987 M.M.of the Skin. APMIS Suppli Danish Cancer Society Epidemiology. 1993; 3:149–55.
  3. Katsambas A, Nicolaidou E. Cutaneous Malignant Melanoma and Sun Exposure. Recent Developments in Epidemiology. Arch Dermatol. 1996; 132(4):444–50.
  4. Mason MD, Allman R, Quibell M. Adhesion molecules in melanoma – more than just superglue. JR Soc Med. 1996; 89(7):393–5.
  5. American Joint Committee on Cancer. Malignant melanoma of the skin. American Joint Committee on Cancer: AJCC Cancer Staging Manual. 5th ed.1997; Philadelphia, Pa: Lippincott-Raven, 163-70.
  6. Neligan CP. Plastic Surgery, 3rd edition. Elsevier Saunders.2013.

Articole din ediţiile anterioare

BASIC RESEARCH IN CANCER | Ediţia 4 49 / 2019

Monitorizarea statusului oxidativ la pacienţii cu melanom uveal în timpul tratamentului oncologic

Maria Alexandra Budirinca, Maria Iuliana Gruia, Gabriela Murgoi, Rodica ANGHEL

Melanomul uveal este cea mai frecventă malignitate primară a ochiului la adulţi. Se cunosc puţine date despre etiologia sa. Factorii de risc includ...

14 decembrie 2019
CASE REPORT | Ediţia 1 46 / 2019

Un caz clinic de melanom malign de spate

Bogdan Mircea Măciuceanu-Zărnescu, Matei Iordache

Melanomul malign are o incidenţă tot mai mare în fiecare an, în special la bărbaţii mai în vârstă. Fiind o boală gra­vă cu multe complicaţii posibi...

27 aprilie 2019
ONCOLOGICAL SURGERY | Ediţia 2 47 / 2019

Proteina C reactivă (PCR) şi leucocitele din lichidul peritoneal – rol în predicţia fistulelor digestive înalte

Virgiliu Mihail Prunoiu, Marian Augustin Marincaş, Tudor Marian Proca, Maria Manuela Răvaş, Eugen Bratucu

Fistulele anastomotice în chirurgia digestivă re­pre­zin­tă o complicaţie gravă, care poate duce la decesul pa­cien­tu­lui. Identificarea unor prob...

16 mai 2019
REVIEW | Ediţia 2 51 / 2020

Managementul tratamentului şi urmărirea pacienţilor cu melanom malign în perioada pandemiei de COVID-19

Daniela Zob, Cornelia Niţipir, Laura Mazilu, Gabriela Niculai, Alina Moldovan, Lidia Kajanto, Andra-Iulia Suceveanu, Radu Florin, Silviu VOINEA, Viorel Savin, Amalia Constantinescu, A. Grigorescu, Raluca Mihaila, Conf. dr. Dana Lucia Stănculeanu

Melanomul este o problemă de sănătate publică, prin in­ci­den­ţa sa în creştere şi prin vârsta mică la diagnostic. Există trei subtipuri de melanom...

19 mai 2020